Health Condition 1: F20- Schizophrenia
Conditions
Interventions
Intervention1: Homoeopathic Chlorpromazinum: After enrollment the cases will be randomized and allocated into two groups viz group A & group B, Homoeopathic Chlorpromazinum will be given to subjects i
Sponsors
Dr S Sudheer Kumar
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of all genders 2. Ages between 18 and 65 years of age 3. Subjects fulfilling ICD 10 diagnostic criteria of Schizophrenia. (F20) 4. Patients under Antipsychotic medication
Exclusion criteria
Exclusion criteria: 1. Patients with comorbid neuro-psychiatric disorders 2. Patients with serious systemic illness. 3. Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of reduction in positive symptoms of Schizophrenia using Scale for Assessment of Positive Symptoms, after administration of Homoeopathic Chlorpromazinum and Individualized Homoeopathic Medicine in respective groups.Timepoint: Every month from baseline till the conclusion of the study(6th month) | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of overall improvement in the symptoms of Schizophrenia using Positive and Negative Syndrome Scale, after administration of Homoeopathic Chlorpromazinum and Individualized Homoeopathic Medicine in respective groups.Timepoint: At the baseline and end of the study(6th month);Assessment of reduction in the Side-effects of antipsychotic medications using Glasgow Anti-Psychotics Side-effect Scale after administration of Homoeopathic Chlorpromazinum and Individualized Homoeopathic Medicine in respective groups.Timepoint: Baseline, at 3rd,and conclusion of the study(6th month) | — |
Countries
India
Contacts
Public ContactDr Deepthi Gilla
National Homoeopathy Research Institute in Mental Health
Outcome results
None listed